WealthPLAN Partners’s T2 Biosystems, Inc TTOO Stock Holding History

WealthPLAN Partners’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5	Closed	-$36	–	1237
2023 Q2	$36	Hold	5	–	–	﹤0.01%	1247
2023 Q1	$233	Buy	+5	New	+$546	﹤0.01%	1273
2022 Q1	$9K	Hold	5	–	–	﹤0.01%	381
2021 Q4	$11K	Hold	5	–	–	﹤0.01%	379
2021 Q3	$14K	Hold	5	–	–	﹤0.01%	372
2021 Q2	$26K	Hold	5	–	–	﹤0.01%	354
2021 Q1	$32K	Hold	5	–	–	﹤0.01%	330
2020 Q4	$61K	Hold	5	–	–	0.01%	329
2020 Q3	$31K	Hold	5	–	–	﹤0.01%	311
2020 Q2	$40K	Hold	5	–	–	﹤0.01%	305
2020 Q1	$14K	Buy	+5	New	+$20.8K	﹤0.01%	253

Other funds holding TTOO

Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

WealthPLAN Partners's TTOO Position: Q3 2023 in Review

WealthPLAN Partners sold out of T2 Biosystems, Inc (TTOO) in Q3 2023, closing a stake of 5 shares — an estimated $36 sold.

WealthPLAN Partners first reported a position in TTOO in Q1 2020 and held it in 11 quarters. The position peaked at $61K in Q4 2020. 40 funds tracked by Wall St. Rank hold TTOO as of Q3 2023.

WealthPLAN Partners reported no remaining T2 Biosystems, Inc position as of Q3 2023 after selling out during the quarter.
WealthPLAN Partners sold 5 T2 Biosystems, Inc shares in Q3 2023, an estimated $36.
WealthPLAN Partners first reported a position in T2 Biosystems, Inc in Q1 2020 and held it in 11 quarters.
WealthPLAN Partners's T2 Biosystems, Inc position peaked at $61K in Q4 2020.
40 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2023.

Based on WealthPLAN Partners's 13F filing for Q3 2023, filed 2 Nov 2023.